Clinical significance of spontaneous Aeromonas bacterial peritonitis in cirrhotic patients: A matched case-control study

Clinical Infectious Diseases

Volumn 47, Issue 1, 2008, Pages 66-72

  Choi, Jae Phil ^a,b   Lee, Sang Oh ^a,b   Kwon, Hyun Hee ^c   Yee, Gyung Kwak ^d   Choi, Seong Ho ^a,b   Seung, Kwan Lim ^a,b   Mi, Na Kim ^a   Jeong, Jin Yong ^a,b   Choi, Sang Ho ^a,b   Jun, Hee Woo ^a,b   Yang, Soo Kim ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; ANTIINFECTIVE AGENT;

ADULT; AEROMONAS; AEROMONAS HYDROPHILA; AEROMONAS SORBIA; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTER INFECTION; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; SURVIVAL RATE; CASE CONTROL STUDY; CLASSIFICATION; DIARRHEA; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HOSPITALIZATION; INCIDENCE; ISOLATION AND PURIFICATION; KLEBSIELLA; MICROBIOLOGY; MIDDLE AGED; PERITONITIS; RETROSPECTIVE STUDY; SEASON; STREPTOCOCCUS; SURVIVAL;

ADULT; AEROMONAS; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DIARRHEA; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; KLEBSIELLA; KLEBSIELLA INFECTIONS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PERITONITIS; PROGNOSIS; RETROSPECTIVE STUDIES; SEASONS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SURVIVAL;

EID: 46249092204     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/588665     Document Type: Article

References (28)

1. Ko WC, Chuang YC. Aeromonas bacteremia: review of 59 episodes. Clin Infect Dis 1995; 20:1298-304.
2. Ko WC, Lee HC, Chuang YC, Liu CC, Wu JJ. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect 2000; 40:267-73.
3. Llopis F, Grau I, Tubau F, Cisnal M, Pallares R. Epidemiological and clinical characteristics of bacteraemia caused by Aeromonas spp. as compared with Escherichia coli and Pseudomonas aeruginosa. Scand J Infect Dis 2004; 36:335-41.
4. Lau SM, Peng MY, Chang FY. Outcomes of Aeromonas bacteremia in patients with different types of underlying disease. J Microbiol Immunol Infect 2000; 33:241-7.
5. Tsai MS, Kuo CY, Wang MC, Wu HC, Chien CC, Liu JW. Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. J Microbiol Immunol Infect 2006; 39:150-4.
6. Muñoz P, Fernández-Baca V, Peláez T, Sánchez R, Rodríguez-Créixems M, Bouza E. Aeromonas peritonitis. Clin Infect Dis 1994; 18:32-7.
7. Park YH, Lee HC, Song HG, et al. Recent increase in antibiotic-resistant microorganisms in patients with spontaneous bacterial peritonitis adversely affects the clinical outcome in Korea. J Gastroenterol Hepatol 2003; 18:927-33.
8. Kuo CH, Changchien CS, Yang CY, Sheen IS, Liaw YF. Bacteremia in patients with cirrhosis of the liver. Liver 1991; 11:334-9.
9. Motyl MR, McKinley G, Janda JM. In vitro susceptibilities of Aeromonas hydrophila, Aeromonas sorbia, and Aeromonas caviae to 22 antimicrobial agents. Antimicrob Agents Chemother 1985; 28:151-3.
10. Vila J, Marco F, Soler L, Chacon M, Figueras MJ. In vitro antimicrobial susceptibility of clinical isolates of Aeromonas caviae, Aeromonas hydrophila and Aeromonas veronii biotype sorbia. Antimicrob Agents Chemother 2002; 49:701-2.
11. Ko WC, Yu KW, Liu CY, Huang CT, Leu HS, Chuang YC. Increasing antibiotic resistance in clinical isolates of Aeromonas strains in Taiwan. Antimicrob Agents Chemother 1996; 40:1260-2.
12. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32:142-53.
13. Runyon BA, Hoefs JC. Culture negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 1984; 4:1209-11.
14. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-70.
15. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55.
17. Snower DP, Ruef C, Kuritza AP, Edberg SC. Aeromonas hydrophila infection associated with the use of medicinal leeches. J Clin Microbiol 1989; 27:1421-2.
18. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-35.
19. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 16th informational supplement. CLSI document M100-S15. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.
20. Wu CJ, Wu JJ, Yan JJ, et al. Clinical significance and distribution of putative virulence markers of 116 consecutive clinical Aeromonas isolates in southern Taiwan. J Infect 2007;54:151-8.
21. Huang LJ, Chen HSP, Chen TL, et al. Secondary Aeromonas peritonitis is associated with polymicrobial ascites culture and absence of liver cirrhosis compared to primary Aeromonas peritonitis. APMIS 2006;114:772-8.
22. Kang JM, Kim BN, Choi SH, et al. Clinical features and prognostic factors of Aeromonas bacteremia. Infect Chemother 2005; 37:161-6.
23. Von Graevenitz A. The role of Aeromonas in diarrhea: a review. Infection 2007; 35:59-64.
24. Agger WA, McCormick JD, Gurwith MJ. Clinical and microbiological features of Aeromonas hydrophila-associated diarrhea. J Clin Microbiol 1985; 21:909-13.
25. Picard B, Goullet P. Seasonal prevalence of nosocomial Aeromonas hydrophilia infection related to Aeromonas in hospital water. J Hosp Infect 1987; 10:152-5.
26. Funada H, Matsuda T. Aeromonas bacteremia in patients with hematologic diseases. Intern Med 1997; 36:171-4.
27. Walsh TR, Payne DJ, MacGowan AP, Benntt PM. A clinical isolate of Aeromonas sobria with three chromosomally mediated inducible β-lactamases: a cephalosporinase, a penicillinase and a third enzyme, displaying carbapenemase activity. J Antimicrob Chemother 1995; 35:271-9.
28. Fosse T, Giraud-Morin C, Madinier I, Mantoux F, Lacour JP, Ortonne JP. Aeromonas hydrophila with plasmid-borne class A extended-spectrum β-lactamase TEM-24 and three chromosomal class B, C, and D β-lactamases, isolated from a patient with necrotizing fasciitis. Antimicrob Agents Chemother 2004; 48:2342-3.